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Abstract
OBJECTIVE—Recent studies have demonstrated that central line–associated bloodstream 
infections (CLABSIs) are preventable through implementation of evidence-based prevention 
practices. Hospitals have reported CLABSI data to the Centers for Disease Control and Prevention 
(CDC) since the 1970s, providing an opportunity to characterize the national impact of CLABSIs 
over time. Our objective was to describe changes in the annual number of CLABSIs in critical care 
patients in the United States.
DESIGN—Monte Carlo simulation.
SETTING—US acute care hospitals.
PATIENTS—Nonneonatal critical care patients.
METHODS—We obtained administrative data on patient-days for nearly all US hospitals and 
applied CLABSI rates from the National Nosocomial Infections Surveillance and the National 
Healthcare Safety Network systems to estimate the annual number of CLABSIs in critical care 
patients nationally during the period 1990–2010 and the number of CLABSIs prevented since 
1990.
RESULTS—We estimated that there were between 462,000 and 636,000 CLABSIs in 
nonneonatal critical care patients in the United States during 1990–2010. CLABSI rate reductions 
led to between 104,000 and 198,000 fewer CLABSIs than would have occurred if rates had 
remained unchanged since 1990. There were 15,000 hospital-onset CLABSIs in nonneonatal 
critical care patients in 2010; 70% occurred in medium and large teaching hospitals.
CONCLUSIONS—Substantial progress has been made in reducing the occurrence of CLABSIs 
in US critical care patients over the past 2 decades. The concentration of critical care CLABSIs in 
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medium and large teaching hospitals suggests that a targeted approach may be warranted to 
continue achieving reductions in critical care CLABSIs nationally.
Surveillance and prevention activities related to healthcare-associated infections (HAIs) have 
undergone enormous changes over the past several decades in the United States. The Centers 
for Disease Control and Prevention (CDC) began systematic collection of HAI data during 
the 1970s through the National Nosocomial Infections Surveillance (NNIS) system, to 
which volunteer hospitals routinely reported HAI surveillance data for aggregation in a 
national database.1 Through the 1990s the NNIS system expanded the use of common 
methods and measures, implemented standardized risk-adjustment techniques for HAI rates, 
and facilitated access to local data for action at healthcare facilities. In 2005, the CDC 
launched the National Healthcare Safety Network (NHSN) surveillance system, which 
integrates and expands components of the NNIS and several other healthcare epidemiology 
surveillance systems at the CDC.2 National HAI surveillance activities have grown rapidly 
under the NHSN through increases in voluntary participation, expansion of surveillance to a 
wider array of healthcare settings, mandatory reporting of HAIs in states, and Centers for 
Medicare and Medicaid Services (CMS) reporting incentives.3–5
Greater standardization of measures created a foundation for assessing the impact of HAI 
prevention strategies and helped stimulate the infection prevention community to develop 
and evaluate HAI prevention measures. Numerous technological innovations and prevention 
initiatives have been developed over time to prevent HAIs generally as well as central line-
associated bloodstream infections (CLABSIs) specifically. These have included the 
introduction of alcohol-based hand rub into healthcare facilities, the use of antimicrobial 
catheters and chlorhexidine insertion site patches, and implementation of infection control 
bundles (ie, groups of interventions implemented simultaneously) utilizing collaborative 
networks of healthcare organizations to disseminate best practices.6–11 These successes 
helped bolster perceptions that HAIs are preventable.
Although data have been systematically collected on HAIs for several decades, 
quantification of changes in the number of HAIs occurring nationally over time is 
challenging due to implementation of refinements in surveillance methodology as well as 
changes in the types of facilities participating in surveillance. Given widespread efforts to 
prevent CLABSIs, especially in critical care settings, our objective was to estimate changes 
in the total number of CLABSIs in critical care patients nationally from 1990 to 2010 and 
the number of infections potentially prevented over that time period.
METHODS
Our conceptual approach for generating national estimates of the number of CLABSIs in 
hospitalized critical care patients involved several steps. We first obtained data on the total 
number of critical care patient-days in the United States each year (excluding neonates). 
Next, we obtained data on CLABSI rates in critical care units reporting data to the NNIS 
(1990–2004) and the NHSN (2006–2010), adjusting for changes in the CLABSI definition 
and surveillance participants over time as well as the possibility that bias was introduced 
when transitioning from the NNIS to the NHSN in 2005. We then applied adjusted critical 
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care CLABSI rates to national patient-day denominators to estimate the annual number of 
critical care CLABSIs. Analyses were conducted using SAS, version 9.1 (SAS Institute), 
and @Risk for Excel, version 5.7 (Palisade).
Patient-Day Denominators
CMS hospital cost reports provide data on patient-days occurring in critical care units in all 
Medicare-certified US hospitals.12 We obtained CMS hospital cost reports for 1990–2009 
and used information from all 20 years of reports to classify hospitals into major types: 
small (less than 200 beds) teaching, medium (201–500 beds) teaching, large (more than 500 
beds) teaching, small nonteaching, medium nonteaching, and large nonteaching. Patient-day 
estimates from the hospital cost report were inflated by between 5% and 10% each year 
because federal hospitals do not file hospital cost reports with the CMS. This inflation factor 
was estimated from the annual ratio of all patient-days to nonfederal patient-days reported to 
the American Hospital Association13 by means of a weighted linear regression model. We 
used linear spline regression to project critical care patient-days forward to 2010 (2009 was 
the most recent complete data year) and to generate standard errors around annual patient-
day estimates for these 6 acute care hospital types.
CLABSI Definition Change
NHSN CLABSI criterion 2b—which considered patients to have a CLABSI if they had an 
intravascular line, had signs or symptoms of infection, had a common commensal organism 
cultured from at least 1 blood sample, and had appropriate antimicrobial therapy initiated by 
a physician—was eliminated on January 1, 2008.14 We analyzed 2006 and 2007 NHSN data 
to estimate the proportion of CLABSIs that were reported via this criterion for each of the 6 
hospital types by means of logistic regression. For all NNIS and NHSN years prior to 2008, 
the number of reported CLABSIs was discounted by this proportion to estimate the number 
of CLABSIs that would have been reported had the 2008 definition been used for all years.
Changes in CLABSI Surveillance Participants
We constructed a negative binomial model for each hospital type on the basis of data 
reported to the NNIS and NHSN from critical care units during the period 1990–2010 to 
generate annual estimated critical care CLABSI rates in cases per 1,000 patient-days. Each 
model included a term for year, a term for whether the data came from the NNIS or NHSN 
system, and a product term that allowed annual rate changes to differ between the NNIS and 
NHSN periods. To adjust for changes in the types of hospitals reporting data, an average of 
the 6 predicted CLABSI rates was calculated each year, weighted by the estimated number 
of national critical care patient-days occurring in each of the 6 hospital types (ie, annual 
CLABSI rates were standardized to the estimated national distribution of critical care 
patient-days by hospital type).
Transition from the NNIS to the NHSN
After adjusting for the CLABSI definition change and changes in surveillance participants, 
we constructed 3 scenarios to address the possibility that the transition from the NNIS to the 
NHSN could have biased the assessment of changes in CLABSI rates over time. In scenario 
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1, we considered the predicted critical care CLABSI rates to be an unbiased reflection of the 
annual CLABSI rates for all critical care units in US hospitals, with no adjustments made to 
CLABSI rates in NNIS years. In scenario 2, we systematically reduced NNIS rates during 
the period 1990–2004 to force the percent change in rates between 2004 and 2006 to be 
consistent with the average annual changes in critical care CLABSI rates observed during 
1990–2004, essentially considering any excess reduction in CLABSI rates between 2004 and 
2006 to be a surveillance artifact. In scenario 3, we discounted NNIS rates by only half of 
the discount applied in scenario 2.
Annual Number of CLABSIs and Infections Prevented for 3 Scenarios
For each of the 3 scenarios, the annual number of CLABSIs was calculated by applying 
annual critical care CLABSI rates (adjusted for definition and participation changes) to the 
estimated number of critical care patient-days nationally each year.
To estimate the number of critical care CLABSIs potentially prevented each year, we 
compared the estimated annual number of CLABSIs to an estimate produced assuming that 
there was no change in hospital type-specific CLABSI rates after 1990; this reflects an 
estimate of what would have occurred each year if no additional changes had occurred in 
critical care CLABSI rates since 1990 in each of the 6 hospital types.
Monte Carlo Simulation
We used Monte Carlo simulation to quantify the uncertainty around all estimates presented 
in this analysis. Input distributions were created using predicted values and standard errors 
from the linear models (patient-days and federal inflation factor), logistic model (CLABSI 
definition change), and negative binomial models (CLABSI rates) described above. We 
sampled values from each of the input distributions in 10,000 simulation cycles and used the 
sampled values to calculate CLABSI estimates for each cycle. We calculated 95% credible 
intervals on the basis of the 2.5th and 97.5th percentiles of all output distributions.
RESULTS
Patient-Day Denominators
The estimated national number of critical care patient-days (excluding neonates) in acute 
care hospitals dropped from an estimated 19.9 million (95% credible interval, 19.1–20.7 
million) in 1990 to 16.9 million (16.2–17.6 million) in 1996 before rising to 21.6 million 
(20.0–23.1 million) in 2010 (Figure 1). The largest total numbers of patient-days in 2010 
were observed in medium and large teaching hospitals, with 7.1 million (6.6–7.6 million) 
and 5.7 million (5.3–6.1 million) patient-days, respectively.
CLABSI Definition Change
Analysis of NHSN data for 2006–2007 indicated that 15% of all reported CLABSIs met the 
NHSN criterion 2b case definition. As such, we applied an average discount multiplier of 
0.85 (0.80–0.90) to the number of CLABSIs reported for all NNIS and NHSN years prior to 
2008 to make CLABSI rates comparable across the definition change.
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Differences in CLABSI Surveillance Participants
The number of critical care units reporting CLABSI data to the CDC increased from 144 in 
1990 to 3,794 in 2010; critical care patient-days under surveillance increased from about 
236,000 to 11.4 million. In addition, the proportion of critical care patient-days under 
surveillance contributed by large teaching hospitals decreased from a high of 57% in 1990 to 
a low of 24% in 2010 (Figure 2A), while the estimated proportion of patient-days occurring 
nationally in large teaching hospitals remained relatively stable (Figure 2B).
Annual participation- and definition-adjusted critical care CLABSI rates (ie, standardized to 
the national distribution of patient-days) declined during both NNIS and NHSN years, with 
average annual rate changes of approximately −1.5% (−2.0% to −0.9%) and −10.4% 
(−11.7% to −9.0%), respectively (Figure 3). CLABSI rates adjusted for participation were 
lower than rates adjusted only for the definition change during the NNIS years because 
hospital types with higher CLABSI rates were overrepresented in the NNIS (Figure 2).
Transition from the NNIS to the NHSN
We observed a large decline in definition- and participation-adjusted critical care CLABSI 
rates between 2004 and 2006 (the transition period from the NNIS to the NHSN; Figure 3). 
The observed percent change in standardized critical care CLABSI rates during the 2-year 
transition period was −33.9% (−38.7% to −29.1%); this was considered scenario 1. We 
applied a discount multiplier of 0.68 to CLABSIs reported during the NNIS period for 
scenario 2 to achieve a change of −2.6% (−9.6% to 4.6%) from 2004 to 2006, consistent 
with annual declines observed in the NNIS from 1990 to 2004. We applied a discount 
multiplier of 0.84 to CLABSI rates during the NNIS period for scenario 3, resulting in a 2-
year transition period change of −21.3% (−26.9% to −15.4%).
Annual Number of CLABSIs and Infections Prevented for 3 Scenarios
The estimated annual number of hospital-onset CLABSIs in nonneonatal critical care 
patients decreased from 41,000 (38,000–45,000), 28,000 (26,000–30,000), and 35,000 
(32,000–37,000) in 1990 for scenarios 1, 2, and 3, respectively, to 15,000 (14,000–17,000) 
in 2010 (all scenarios). The 3 scenarios corresponded to an estimated 636,000 (609,000–
666,000), 462,000 (441,000–484,000), and 549,000 (525,000–575,000) cumulative 
CLABSIs, respectively, over the 21-year period (Table 1). Of the estimated 15,000 hospital-
onset CLABSIs in nonneonatal critical care patients in 2010, a minority occurred in 
nonteaching or small teaching hospitals. Approximately 70.4% (68.9%–71.9%) of hospital-
onset CLABSIs in critical care patients occurred in medium and large teaching hospitals.
For each of the 3 scenarios, the annual number of critical care CLABSIs that would have 
occurred if rates had not changed since 1990 decreased between 1990 and 1996 and 
increased each subsequent year through 2010. These 3 scenarios corresponded to 834,000 
(771,000–912,000) CLABSIs for scenario 1, 566,000 (521,000–621,000) for scenario 2, and 
700,000 (646,000–766,000) for scenario 3 cumulatively over the 21-year period (Table 1). 
Thus, from 1990 to 2010 the difference in the cumulative estimated number of CLABSIs 
that would have occurred and cumulative estimated CLABSIs that did occur (ie, CLABSIs 
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potentially prevented) was 198,000 (149,000–261,000) for scenario 1, 104.000 (70,000–
147,000) for scenario 2, and 151,000 (110,000–204,000) for scenario 3 (Table 1).
DISCUSSION
We estimated that from 1990 to 2010 there were between 462.000 and 636,000 hospital-
onset CLABSIs in nonneonatal critical care patients in the United States, depending on 
assumptions about the surveillance system transition. As a result of CLABSI rate reductions 
over this time period, these cumulative totals correspond to between 104,000 and 198,000 
fewer CLABSIs than would have occurred if rates had remained unchanged since 1990. 
These findings suggest that technical innovations and dissemination of evidence-based 
CLABSI prevention practices have likely been effective on a national scale.
Despite the apparent prevention success, we estimated that there were still approximately 
15,000 hospital-onset CLABSIs in critical care settings in 2010. Of these, almost three-
quarters occurred in teaching hospitals with more than 200 beds. What fraction of these 
remaining CLABSIs are preventable with current infection control interventions is unclear,15 
but our observation suggests that these facilities, which likely number fewer than 800 (on the 
basis of CMS hospital cost report data), should be specifically targeted with interventions to 
further reduce CLABSIs nationally. The majority of CLABSI prevention programs 
implemented over the past decade have focused on sterile insertion of central lines; further 
reduction in hospital-onset CLABSIs might require inclusion of improved catheter 
maintenance in prevention bundles.9,16–18 In addition, given the progress made in reducing 
CLABSIs in critical care settings, the contribution of patients in other at-risk clinical settings 
to the total CLABSI burden might now be comparable to inpatient critical care,19 
representing logical additional targets for focused intervention; these settings may include 
high-risk inpatient wards and outpatient hemodialysis centers.
In an analysis of NNIS and NHSN data published in the March 2011 Morbidity and 
Mortality Weekly Report, we estimated that there were 58% fewer critical care CLABSIs in 
2009 than would have occurred if rates had not changed since 2001.19 The current analysis, 
in which we produced adjusted annual CLABSI estimates for a 21-year period and 
considered 3 different scenarios to account for the transition from the NNIS to the NHSN, 
demonstrated between 34.0% (31.3%–36.6%) and 55.2% (53.4%–57.0%) fewer CLABSIs 
in 2009 than would have been expected on the basis of 2001 rates. One important difference 
in the former analysis is that temporal changes in the underlying patient population at risk 
were addressed by applying 2001 and 2009 CLABSI rates to the same patient-day 
denominator. We took a complementary approach for the current analysis, in which we 
estimated the number of CLABSIs occurring each year allowing patient-days to change over 
time, comparing each year’s observed estimate to an expected estimate based on what would 
have occurred if CLABSI rates had not changed since 1990. This difference is analogous to 
direct versus indirect standardization20 and, along with adjustments for participation and the 
system transition, explains the differences in estimates presented in the 2 analyses.
The large decrease observed in definition- and participation-adjusted CLABSI rates between 
2004 and 2006 (33.9%) was likely a result of several factors acting in concert. During this 
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period there may have been increasing awareness of CLABSI prevention successes being 
reported by large prevention initiatives. The Pittsburgh Regional Health Initiative and the 
Michigan Keystone project are 2 examples of evidence-based prevention programs that 
achieved large reductions in critical care CLABSI rates that were widely publicized during 
this time.6,7 Dissemination of successes like these during the NNIS-NHSN transition period 
may have contributed to a steepening of rate declines nationally. However, the steep change 
in rates observed with the transition from the NNIS to the NHSN also raises the possibility 
of an artifactual decrease in reported rates resulting from the surveillance system change. 
The lack of a disproportionate decline in observed rates during the transition period for 
catheter-associated urinary tract infections21 and ventilator-associated pneumonias22 argues 
against this explanation, however. Of note, a rate reduction similar to the reduction in 
scenario 1 was observed for CLABSIs between 2004 and 2006 in a network of community 
hospitals reporting to a different surveillance system,23 which had no change in surveillance 
methodology during that time (D. Sexton, personal communication). This independent 
observation suggests that the decline in rates observed during the NNIS-NHSN transition 
period should not be completely attributed to an artifact resulting from the change in 
surveillance systems. Nevertheless, because we are unable to estimate the relative 
contribution of these factors to the observed decline in CLABSI rates during the transition, 
we opted to present multiple potential scenarios for this period. As state and national 
reporting requirements were primarily implemented in years subsequent to the system 
transition, public reporting mandates were not an important factor in the observed decline 
from 2004 to 2006.5
Our analysis was subject to several limitations. We could adjust for participation changes 
only on the basis of facility characteristics (ie, teaching status and bed size), since patient-
day data from the CMS hospital cost report are not stratified into critical care unit types 
comparable to those used in the NNIS and NHSN. In addition, relatively few data were 
reported from small and large nonteaching hospitals in the NNIS era. We also assumed that 
data reported to the NNIS and NHSN within each of the 6 facility types were representative 
of all nonparticipating facilities in those categories nationally. Comparisons across facility 
types may also be complicated by variability in how surveillance is implemented.24 
Furthermore, the use of 1990 CLABSI rates as a surrogate for what would have occurred in 
the absence of CLABSI prevention activities is somewhat arbitrary; changes in factors not 
directly related to infection prevention over time could have caused rates to increase or 
decrease over time, such as pressure to reduce critical care unit length of stay and changes in 
empiric antimicrobial prescribing practices. Finally, the estimates we present in this analysis 
are limited to hospital-onset infections in nonneonatal critical care patients; national 
CLABSI estimates that include all patient populations may need an alternative approach, 
such as can be accomplished through a point prevalence survey.
More work remains in preventing hospital-onset CLABSIs in critical care patients, with 
more than 15,000 infections occurring in 2010. Given the high mortality and excess 
healthcare costs associated with CLABSIs, these infections still have a major impact on 
patients and the healthcare system. The current concentration of critical care CLABSIs in 
medium and large teaching hospitals suggests that a targeted approach may be warranted to 
most efficiently continue achieving reductions in critical care CLABSIs nationally. 
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Nevertheless, our analysis suggests that substantial progress has been made in the prevention 
of hospital-onset CLABSIs in critical care patients in the United States over the past 2 
decades. Lessons learned from this success have already provided a foundation for efforts to 
prevent other important HAIs on a national scale.
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FIGURE 1. 
Estimated annual number of national critical care patient-days, excluding neonates, by acute 
care hospital type, United States, 1990–2010.
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FIGURE 2. 
Annual distribution of critical care patient-days reported to the National Nosocomial 
Infections Surveillance and National Healthcare Safety Network systems (A) and estimated 
annual distribution of national critical care patient-days (B), excluding neonates, by acute 
care hospital type, United States, 1990–2010.
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FIGURE 3. 
Hospital-onset central line-associated bloodstream infection (CLABSI) rates (cases per 
1,000 critical care patient-days) adjusted for CLABSI definition change, surveillance 
participation changes, and system transition, excluding neonates, United States, 1990–2010.
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TABLE 1
Estimates for Cumulative Number of Hospital-Onset CLABSIs, Cumulative Number of Hospital-Onset 
CLABSIs That Would Have Occurred on the Basis of 1990 Rates, and Cumulative Number of CLABSIs 
Prevented for 3 NNIS-NHSN Transition Scenarios in Critical Care Patients, Excluding Neonates, United 
States, 1990–2010
Cumulative no. of CLABSIs
Cumulative no. of CLABSIs on the basis of 1990 
rates Cumulative no. of CLABSIs prevented
Scenario 1 636,000 (609,000–666,000) 834,000 (771,000–912,000) 198,000 (149,000–261,000)
Scenario 2 462,000 (441,000–484,000) 566,000 (521,000–621,000) 104,000 (70,000–147,000)
Scenario 3 549,000 (525,000–575,000) 700,000 (646,000–766,000) 151,000 (110,000–204,000)
NOTE. Data in parentheses are 95% credible intervals. CLASBI, central line-associated bloodstream infection; NHSN, National Healthcare Safety 
Network; NNIS, National Nosocomial Infections Surveillance.
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